 - Patients with histologically or cytologically documented squamous cell nonsmall-cell lung cancer who present with Stage IIIBStage IV disease according to version 7 of the International Association for the Study of Lung Cancer Staging Manual in Thoracic Oncology, or with recurrent or progressive disease following multimodal therapy radiation therapy, surgical resection, or definitive chemoradiation for locally advanced disease 